Abstract
Tumor necrosis factor-alpha (TNF-α) is a multifunctional cytokine produced by monocytes, macrophages, neutrophils, T-cells, mast cells, epithelial cells, osteoblasts and dendritic cells. It can regulate numerous cellular and biological processes such as immune function, cell differentiation, proliferation, apoptosis and energy metabolism. It is also involved in the pathogenesis of multiple chronic inflammatory or autoimmune diseases. The biological activities of TNF-α mediated by two receptors TNFR1 and TNFR2. Its activity can be inhibited by neutralizing monoclonal antibodies or soluble TNF receptors. The inhibition of its biological activities using anti TNF-α antibodies represents an approved strategy for the treatment of various diseases like cancer, autoimmune diseases, inflammations etc. The involvement of TNF-α cytokine in the various types of diseases provide the therapeutic rationale for the development of TNF-α antagonist. A large number of natural and synthetic compounds are currently being investigated for TNF-α inhibitory activity. Since the synthetic molecules are always associated with their side effects hence it is beneficial to develop the natural strategies as the alternative sources. There are many medicinal plants which are traditionally used for the treatment of the diseases associated with TNF-α inhibition. Hence, in this review article we make an approach to provide a platform for the development of TNF-α antagonist from natural resources.
Keywords: Anti-inflammatory, Natural products, Tumor necrosis factor-alpha (TNF-α), multiple chronic inflammatory or autoimmune diseases, cancer, autoimmune diseases, inflammations, chills, fever, and other, flu-like symptoms
Current Topics in Medicinal Chemistry
Title:Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Volume: 12 Issue: 13
Author(s): Praveen Kumar Verma, Manju Bala, Neeraj Kumar and Bikram Singh
Affiliation:
Keywords: Anti-inflammatory, Natural products, Tumor necrosis factor-alpha (TNF-α), multiple chronic inflammatory or autoimmune diseases, cancer, autoimmune diseases, inflammations, chills, fever, and other, flu-like symptoms
Abstract: Tumor necrosis factor-alpha (TNF-α) is a multifunctional cytokine produced by monocytes, macrophages, neutrophils, T-cells, mast cells, epithelial cells, osteoblasts and dendritic cells. It can regulate numerous cellular and biological processes such as immune function, cell differentiation, proliferation, apoptosis and energy metabolism. It is also involved in the pathogenesis of multiple chronic inflammatory or autoimmune diseases. The biological activities of TNF-α mediated by two receptors TNFR1 and TNFR2. Its activity can be inhibited by neutralizing monoclonal antibodies or soluble TNF receptors. The inhibition of its biological activities using anti TNF-α antibodies represents an approved strategy for the treatment of various diseases like cancer, autoimmune diseases, inflammations etc. The involvement of TNF-α cytokine in the various types of diseases provide the therapeutic rationale for the development of TNF-α antagonist. A large number of natural and synthetic compounds are currently being investigated for TNF-α inhibitory activity. Since the synthetic molecules are always associated with their side effects hence it is beneficial to develop the natural strategies as the alternative sources. There are many medicinal plants which are traditionally used for the treatment of the diseases associated with TNF-α inhibition. Hence, in this review article we make an approach to provide a platform for the development of TNF-α antagonist from natural resources.
Export Options
About this article
Cite this article as:
Kumar Verma Praveen, Bala Manju, Kumar Neeraj and Singh Bikram, Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist, Current Topics in Medicinal Chemistry 2012; 12 (13) . https://dx.doi.org/10.2174/156802612801784425
DOI https://dx.doi.org/10.2174/156802612801784425 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Challenges, Consequences and Possible Treatments of Anticancer Drug Discovery ll
The use of several compounds has been the subject of increasing interest in phytochemistry, biochemistry, and other fields of research at the chemistry-biology-ecosystems interface. In spite of the continued search for new anticancer drugs, cancer remains a leading cause of death. Cancer mortalities are expected to increase to 12.9 million, ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Vitiligo and Allergic Complications from Orthopaedic Joint Implants: The Role of Benzoyl Peroxide
Recent Patents on Inflammation & Allergy Drug Discovery Cardiovascular Involvement in Pediatric Systemic Autoimmune Diseases: The Emerging Role of Noninvasive Cardiovascular Imaging
Inflammation & Allergy - Drug Targets (Discontinued) Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease
Current Topics in Medicinal Chemistry CCL17/Thymus and Activation-Related Chemokine: A biomarker for Churg-Strauss Syndrome?
Current Biomarkers (Discontinued) Tissue-specific Glucocorticoid Signaling May Determine the Resistance Against Glucocorticoids in Autoimmune Diseases
Current Medicinal Chemistry Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases
Current Pharmaceutical Analysis Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders
Reviews on Recent Clinical Trials Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Contribution of the Rho-kinase to Systemic Sclerosis and Behçet’s Disease
Current Pharmaceutical Design VEGFR1 Signaling Regulates IL-4-Mediated Arginase 1 Expression in Macrophages
Current Molecular Medicine Clinical Queries Addressed in Patients with Systemic Autoimmune Diseases. Can Cardiovascular Magnetic Resonance Give the Final Solution?
Inflammation & Allergy - Drug Targets (Discontinued) Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmunity in Type 1 Diabetes
Current Stem Cell Research & Therapy Mechanisms Leading to Autoantibody Production: Link Between Inflammation and Autoimmunity
Current Drug Targets - Inflammation & Allergy Chitosan Nanoparticles: A Therapeutic Carrier for Delivery of DNA, siRNA and CpG-ODNs
Nanoscience & Nanotechnology-Asia The Long and Winding Road: Searching for Non-MHC Psoriasis Susceptibility Loci
Current Genomics Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
Current Cardiology Reviews Ulcerative Colitis: Pathogenesis
Current Drug Targets